All Blogs / Industries / Medical / Popular

Get More Specific:

Hospitals Urge Congress not to Change a Drug Discount Program

Executives from more than 500 hospitals are urging Congressional leaders not to make changes to a prescription drug program that serves indigent patients and bolsters their own bottom lines.

Fruit Street Health Integrates 175 Apps/Wearables to Telemedicine Platform

Digital wellness and telemedicine platform Fruit Street Health has chosen Validic’s digital health platform to access more than 175 wearable devices and applications into its telehealth software, personal health record and HIPAA compliant...Show More Summary

New York Innovates in Medicaid—But Ignores a Key Member of the Team

By JOSEPH ANTOS and YEVGINY FEYMAN New York has an opportunity to make real improvements to its Medicaid program; but it is leaving out key health care providers which might be best positioned to cut costs and improve value. The state has undertaken a $6.4 billion dollar initiative, the Delivery System Reform Incentive Payment (DSRIP)

Dr. Oz: I have met the enemy. It is us.

Enough already about Dr. Oz. Whichever side you happen to be on, we might collectively acknowledge that much of the noise being made about what is, at worst, a symptom, is itself an indication of a culture-wide disease. The fate of Ozymandias comes to mind. Science is Ozymandias. Soundbites are the ruin of it. Continue […]

Controlling Proteins, One by One

Here's what looks like a very useful method for turning protein function on and off, reported in a new paper in Nature Chemistry. (This PDF link may work for you). The authors, from the MRC Molecular Biology labs at Cambridge (rightShow More Summary

New App for Allscripts Swiftly Fills Cancelled Appointments

QueueDr, a product that fills cancelled appointments in less than 1 minute with no effort required from staff has been named App of the Month by EHR provider, Allscripts for its innovation in patient engagement and care coordination....Show More Summary

Graphene: The Next Medical Revolution

The 2010 Nobel Prize for Physics went to two scientists who found a simple way to isolate a single layer of graphite, called graphene. It is a 2D sheet of carbon atoms arranged in a hexagonal lattice, that makes for the thinnest, most...Show More Summary

An Interview with BID-Plymouth CIO Ron Rutherford and Clinical Informatics Nurse Jean Marie Grupillion

By MICHELLE RONAN NOTEBOOM Michelle Noteboom: Give me a bit of background on your hospital. Ron Rutherford: Jordan Hospital is a 100-plus-year-old, a 155-bed community hospital that actually was acquired and became a part of the Beth Israel Deaconess Health System in January of 2014, so just over a year ago. We’re a full-service community

High Price for Gilead Sciences Hep C Drug Prompts Patent Challenges

Several advocacy groups have filed patent challenges to the blockbuster Sovaldi hepatitis c drug in a bid to widen access to patients in some of the world’s largest countries.

Throwing the kitchen sink at public health problems

The buzzwords many use in medicine today are “personalized,” “individualized,” or “targeted.” Rather than doctors prescribing tests or treatments that work in most people but might not work for you, proponents argue, we should tailor medical interventions to unique patient characteristics, such as genomic data. Show More Summary

Tom Stossel Attempts to Debunk the Conflict-of-Interest "Myth"

Yesterday, I interviewed Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, about his new book, PharmaPhobia, and his call to action against the "Conflict of Interest Movement," which he claims undermines American medical innovation. Show More Summary

A Shout Out For Our Sponsors: HealthCatalyst

By MATTHEW HOLT This fine blog would not be possible without the support of our wonderful corporate underwriters. The days when blogs ran on shoestrings and sticky tape are, alas, long gone. Putting on a show like the one you see on THCB takes considerable resources. Today’s shout out goes out to the fine folks at

New hope for those diagnosed with autism

As I have been known to say on this blog once or twice before, one of my favorite things about being a developmental pediatrician is the opportunity to follow the children I see for initial diagnostic evaluation over the long term. New research presented at the Pediatric Academic Societies conference makes me especially hopeful. Continue reading […]

Pharmalot.. Pharmalitlle.. Good Morning: We’re Catching up on J&J, Sarepta and Lots More!!

Hello, everyone, and nice to see you again. We were away the past few days on what amounted to a long holiday weekend with one of our short people. Besides taking a needed break, creating memories can be important, yes? Now, though, we have returned to the usual routine of deadlines, meetings and the rest. Show More Summary

21st Century Cures Act

I’m in Washington today for the HIT Standards Committee and I will post the usual summary of the meeting this evening. However, I wanted to post a morning preview of the opening comments I’ll make a the meeting.We are in a time of great turmoil in healthcare IT policy making. Show More Summary

The Smoking Gun: How U.S. Health Care Came to Cost Insanely More

By JOE FLOWER Cost is the big factor. Cost is why we can’t have nice things. The overwhelmingly vast pile of money we siphon into health care in the United States every year is the underlying driver of almost every other problem with health care in the United States from lack of access to waste

A Young Blood Controversy

The recent revival of interest in the way that the blood from younger animals (and people?) can improve the health of older ones came bundled with a particular protein candidate for the effect, GDF11. Several papers appeared on its effects...Show More Summary

Leaving medical school for a startup. And with no regrets.

There he stood at our beach party, the family doctor I grew up admiring. I timidly approached his circle of friends to announce I had gotten into medical school and would start in the fall. He stopped to attention. His friends stood watching. I couldn’t conceal my smile. I thought, “He is going to be […]

Folic acid for primary stroke prevention

P { margin-bottom: 0.08in; }A:link { } From the CSPPT RCT: Design, Setting, and Participants The China Stroke Primary Prevention Trial, a randomized, double-blind clinical trial conducted from May 19, 2008, to August 24, 2013, in 32 communities in Jiangsu and Anhui provinces in China. A total of 20?702 adults with hypertension without history of stroke or myocardial

Copyright © 2015 Regator, LLC